Market Research Logo

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review

Dynavax Technologies Corp (DVAX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Dynavax Technologies Corp (Dynavax), formerly Double Helix Corp, is an integrated biopharmaceutical company that develops product candidates for the prevention of infectious and inflammatory disease. Its marketed product Heplisav-B is an adult vaccine which is indicated for the prevention of hepatitis B. The company’s pipeline focuses on combining the innate immune response with other immunomodulatory agents for the treatment of cancer. Its pipeline spans includes immuno-oncology product candidates including a combination of SD-101 and pembrolizumab in Phase 2 clinical studies for the treatment of melanoma, head and neck squamous cell carcinoma, and neoadjuvant breast cancer; and a combination of inhaled DV281 and nivolumabin a Phase 1 safety study for non-small cell lung cancer (NSCLC). Dynavax also has a vaccine candidate, 1018 adjuvant, for pertussis; TLR7/8 agonists for oncological indications; and a cancer vaccine in its pre-clinical pipeline. The company’s immunotherapies harness the power of the human body’s adaptive and innate immune responses through toll-like receptor (TLR) stimulation. It operates through its subsidiary in Germany. Dynavax is headquartered in Berkeley, California, the US.

Dynavax Technologies Corp Key Recent Developments

May 23,2019: Dynavax announces strategic restructuring to focus on its vaccine business
May 08,2019: Dynavax announces first quarter 2019 financial results
Feb 26,2019: Dynavax announces fourth quarter and full year 2018 financial results
Jan 29,2019: Dynavax Technologies names Heather Rowe as vice president of investor relations and corporate communications
Nov 05,2018: Dynavax reports third quarter 2018 financial results, progress on HEPLISAV-B launch, and updated SD-101 data in three patient populations

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Dynavax Technologies Corp - Key Facts
Dynavax Technologies Corp - Key Employees
Dynavax Technologies Corp - Key Employee Biographies
Dynavax Technologies Corp - Major Products and Services
Dynavax Technologies Corp - History
Dynavax Technologies Corp - Company Statement
Dynavax Technologies Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Dynavax Technologies Corp - Business Description
Business Segment: Net Product Revenue
Performance
Business Segment: Other revenue
Performance
R&D Overview
Dynavax Technologies Corp - Corporate Strategy
Dynavax Technologies Corp - SWOT Analysis
SWOT Analysis - Overview
Dynavax Technologies Corp - Strengths
Dynavax Technologies Corp - Weaknesses
Dynavax Technologies Corp - Opportunities
Dynavax Technologies Corp - Threats
Dynavax Technologies Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Dynavax Technologies Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 23, 2019: Dynavax announces strategic restructuring to focus on its vaccine business
May 08, 2019: Dynavax announces first quarter 2019 financial results
Feb 26, 2019: Dynavax announces fourth quarter and full year 2018 financial results
Jan 29, 2019: Dynavax Technologies names Heather Rowe as vice president of investor relations and corporate communications
Nov 05, 2018: Dynavax reports third quarter 2018 financial results, progress on HEPLISAV-B launch, and updated SD-101 data in three patient populations
Aug 28, 2018: Combination approach shows promise for beating advanced melanoma
Aug 06, 2018: Dynavax reports second quarter 2018 financial results
Jun 28, 2018: Dynavax Appoints Scientific Advisory Board to Support its Oncology and Vaccine Programs
May 08, 2018: Dynavax Announces First Quarter 2018 Financial Results
Mar 08, 2018: Dynavax Reports Fourth Quarter and Year End 2017 Financial Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Dynavax Technologies Corp, Key Facts
Dynavax Technologies Corp, Key Employees
Dynavax Technologies Corp, Key Employee Biographies
Dynavax Technologies Corp, Major Products and Services
Dynavax Technologies Corp, History
Dynavax Technologies Corp, Subsidiaries
Dynavax Technologies Corp, Key Competitors
Dynavax Technologies Corp, Ratios based on current share price
Dynavax Technologies Corp, Annual Ratios
Dynavax Technologies Corp, Annual Ratios (Cont...1)
Dynavax Technologies Corp, Interim Ratios
Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Dynavax Technologies Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Dynavax Technologies Corp, Performance Chart (2014 - 2018)
Dynavax Technologies Corp, Ratio Charts
Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Dynavax Technologies Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report